Screening for type II hereditary angioedema—the “poor man’s c1-inhibitor function”
Background: Hereditary angioedema (HAE) is a rare genetic disease. Patients with type II HAE have normal or elevated C1-inhibitor (C1-INH) levels but C1-INH protein is dysfunctional. C1-INH function requires careful sample handling and technical expertise and may account for the lack of diagnosed pa...
Main Authors: | Ankur Kumar Jindal, MD, DM, Valerie Chiang, MBBS, Prabal Barman, MD, Archan Sil, MD, Sanchi Chawla, MSc, Elaine Y.L. Au, MBBS, FRCPA, Amit Rawat, MD, Philip H. Li, MD, FRCP |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Journal of Allergy and Clinical Immunology: Global |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772829323001042 |
Similar Items
-
Preferred Therapy for Patients with Hereditary Angioedema during Pregnancy
by: Kristen Park, et al.
Published: (2023-08-01) -
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
by: Stefan Hintze, et al.
Published: (2023-01-01) -
Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab
by: Jane C.Y. Wong, MBBS, FHKCP, et al.
Published: (2023-11-01) -
Determining biomarkers for evaluation and diagnosis of hereditary angioedema
by: Umesh Singh, et al.
Published: (2022-10-01) -
Altered Urinary Metabolomics in Hereditary Angioedema
by: Xue Wang, et al.
Published: (2022-11-01)